Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma

BACKGROUND: Malignant pleural mesothelioma (MPM) is well known as an aggressive disease with poor survival. This has sparked trials of alternate immune-based therapies in MPM. While up to a quarter of MPM patients respond to immune checkpoint inhibitors (ICIs), predicting response remains challengin...

Full description

Saved in:
Bibliographic Details
Published in:Transl Lung Cancer Res
Main Authors: Brockwell, Natasha K., Alamgeer, Muhammad, Kumar, Beena, Rivalland, Gareth, John, Thomas, Parker, Belinda S.
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2020
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7354134/
https://ncbi.nlm.nih.gov/pubmed/32676326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-485
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items